Signify Premium Insight: Reimbursement Raises Prospects for Cardiac Plaque AI
Published: October 19, 2022
Cleerly recently joined the very exclusive club of medical imaging AI vendors whose solutions are now deemed eligible for reimbursement, with the CMS adding an OPPS code for AI-based coronary plaque assessments.
The move means that Cleerly’s plaque AI solution, as well as similar approved solutions from other vendors, now qualify for reimbursement of between $900 and $1,000, when used with Medicare patients scanned in hospital outpatient settings.
The provisioning of a reimbursement code means that Cleerly joins some of medical imaging AI’s most esteemed vendors, such as HeartFlow, and Perspectum, which are increasingly eroding one of the central barriers to the adoption of medical imaging AI: a clear return on investment for adopters.
Read the full insight with a Signify Premium Insights – Medical Imaging subscriptionSign up for a free trial today.
AI in Medical Imaging Market Intelligence ServiceOngoing series of reports, data and insights delivered over the year
AI in Medical Imaging Market Intelligence Service
This Market Intelligence Service provides regular data, insights and analysis on the global market opportunity for AI-based medical image analysis.
Find out more